BRCA1 and breast cancer: For example, it has been found that the small subgroup of women who have a germline mutation in BRCA1 could be at a considerably reduced risk of breast cancer if they use contemporary oral contraceptives for a year or more [22], whereas the conventional wisdom is that for other women use of current oral contraceptives is associated with a small and transient increase in risk [23].